Cargando…
A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome
INTRODUCTION: Li–Fraumeni syndrome, an autosomal dominant cancer predisposition syndrome caused by a pathogenic variant of TP53, a tumor suppressor gene, leads to a high risk from early childhood of developing various types of cancers. Here, we report a case of advanced ureteral cancer in Li–Fraumen...
Autores principales: | Une, Minami, Fujiwara, Ryo, Ueki, Arisa, Oki, Ryosuke, Urasaki, Tetsuya, Inamura, Kentaro, Takahashi, Shunji, Yonese, Junji, Yuasa, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475342/ https://www.ncbi.nlm.nih.gov/pubmed/37667764 http://dx.doi.org/10.1002/iju5.12607 |
Ejemplares similares
-
A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
por: Oki, Ryosuke, et al.
Publicado: (2022) -
Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy
por: Yasuoka, Shotaro, et al.
Publicado: (2021) -
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
por: Fujiwara, Motohiro, et al.
Publicado: (2021) -
Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
por: Une, Minami, et al.
Publicado: (2021) -
Recent Advances in Medical Therapy for Urological Cancers
por: Yuasa, Takeshi, et al.
Publicado: (2022)